- About Pancreatic Cancer
- Get Support
Caregivers
- Get Involved
- Events
- More
2020-02-21
2022-12-31
2022-12-31
1800
NCT04235556
Assistance Publique - Hôpitaux de Paris
Assistance Publique - Hôpitaux de Paris
OBSERVATIONAL
Integrated Care Pathway in Oncology (PASSION)
A centralized unit for integrated management of care pathway in Oncology has been created. This unit settles the patients' appointments (biopsy, intravenous device, chemotherapy, imaging, oncologist...). The aim of this study is to assess the delay between the first appointment with the oncologist and the beginning of the antitumoral treatment, and therefore evaluate the efficacy of the care pathway unit. The second aim is to assess the satisfaction of patients and health care teams.
PASSION is a french monocentric study. For the retrospective cohort, patient will be selected through the use of data warehouse available on the HEGP. For the prospective cohort, patient will be included according to the selection criteria. Each patient will be followed up during 6 month and a satisfaction questionnaire will be completed at 1 month and 4 month of the first administration of anti-tumor therapy. For both cohort, clinical-anatomo-biological data will be collected through the use of data warehouse available on the HEGP.
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
| Study Registration Dates | Results Reporting Dates | Study Record Updates |
|---|---|---|
2019-12-02 | N/A | 2022-05-12 |
2020-01-17 | N/A | 2022-05-13 |
2020-01-22 | N/A | 2022-05 |
This section provides details of the study plan, including how the study is designed and what the study is measuring.
Primary Purpose:
N/A
Allocation:
N/A
Interventional Model:
N/A
Masking:
N/A
Arms and Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
| : Historic cohort Retrospective cohort of patients that were treated in the Hôpital Européen Georges Pompidou before the creation of the care pathway unit. | |
| : Prospective cohort All consecutive patients that meet the inclusion criterion and will begin a cancer care after the study start. | BEHAVIORAL: Care pathway unit
|
| Primary Outcome Measures | Measure Description | Time Frame |
|---|---|---|
| Time between the first appointment with the oncologist and the beginning of antitumoral treatment. | Delay of health care | 6 months |
| Secondary Outcome Measures | Measure Description | Time Frame |
|---|---|---|
| Patients satisfaction | Satisfaction of patients with OUT-PATSAT35 questionnaire (out-patient satisfaction) : Likert type scale with 5 ordered modalities (bad to excellent), rated from 1 to 5. | 6 months |
| Health care teams satisfaction | Satisfaction of health care teams : qualitative questionnaire with 4 ordered modalities (very satisfied to not satisfied) | 6 months |
| Rate of emergency consultations and hospitalizations | Need for unexpected health care | 6 months |
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.
Ages Eligible for Study:
ALL
Sexes Eligible for Study:
18 Years
Accepts Healthy Volunteers:
This is where you will find people and organizations involved with this study.
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
No publications available
NPCF was founded on May 29, 2009 and is a 501(c)(3) organization. All donations are tax deductible.
The information and services provided by the National Pancreatic Cancer Foundation are for informational purposes only. The information and services are not intended to be substitutes for professional medical advice, diagnosis or treatment. The National Pancreatic Cancer Foundation does not recommend nor endorse any specific physicians, products or treatments even though they may be mentioned on this site.
